nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of LXRβ Signaling in the Amygdala Confers Anxiolytic Effects Through Rebalancing Excitatory and Inhibitory Neurotransmission upon Acute Stress
|
Yu, Wen |
|
|
17 |
3 |
p. 1253-1270 |
artikel |
2 |
Activation of LXRβ Signaling in the Amygdala Confers Anxiolytic Effects Through Rebalancing Excitatory and Inhibitory Neurotransmission upon Acute Stress
|
Yu, Wen |
|
|
17 |
3 |
p. 1253-1270 |
artikel |
3 |
A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas
|
Ho, Kuo-Hao |
|
|
17 |
3 |
p. 1212-1227 |
artikel |
4 |
A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas
|
Ho, Kuo-Hao |
|
|
17 |
3 |
p. 1212-1227 |
artikel |
5 |
Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies
|
Sang, Christine N. |
|
|
17 |
3 |
p. 765-769 |
artikel |
6 |
Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies
|
Sang, Christine N. |
|
|
17 |
3 |
p. 765-769 |
artikel |
7 |
Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study
|
Leong, Sook Ling |
|
|
17 |
3 |
p. 1287-1299 |
artikel |
8 |
Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study
|
Leong, Sook Ling |
|
|
17 |
3 |
p. 1287-1299 |
artikel |
9 |
ASENT2020 Annual Meeting Abstracts
|
|
|
|
17 |
3 |
p. 1311-1323 |
artikel |
10 |
ASENT2020 Annual Meeting Abstracts
|
|
|
|
17 |
3 |
p. 1311-1323 |
artikel |
11 |
CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Yan, Jun |
|
|
17 |
3 |
p. 1170-1183 |
artikel |
12 |
CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice
|
Yan, Jun |
|
|
17 |
3 |
p. 1170-1183 |
artikel |
13 |
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
|
Donnelly, Christopher R. |
|
|
17 |
3 |
p. 846-860 |
artikel |
14 |
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
|
Donnelly, Christopher R. |
|
|
17 |
3 |
p. 846-860 |
artikel |
15 |
Central Nervous System Targets: Inhibitory Interneurons in the Spinal Cord
|
Hughes, David I |
|
|
17 |
3 |
p. 874-885 |
artikel |
16 |
Central Nervous System Targets: Inhibitory Interneurons in the Spinal Cord
|
Hughes, David I |
|
|
17 |
3 |
p. 874-885 |
artikel |
17 |
Central Nervous System Targets: Supraspinal Mechanisms of Analgesia
|
Bannister, K. |
|
|
17 |
3 |
p. 839-845 |
artikel |
18 |
Central Nervous System Targets: Supraspinal Mechanisms of Analgesia
|
Bannister, K. |
|
|
17 |
3 |
p. 839-845 |
artikel |
19 |
Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate
|
Carlström, Karl E. |
|
|
17 |
3 |
p. 1142-1152 |
artikel |
20 |
Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate
|
Carlström, Karl E. |
|
|
17 |
3 |
p. 1142-1152 |
artikel |
21 |
Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?
|
Coyle, Patricia K. |
|
|
17 |
3 |
p. 971-972 |
artikel |
22 |
Commentary: The Multiple Sclerosis Controversy: Is It Escalation or Induction High Efficacy?
|
Coyle, Patricia K. |
|
|
17 |
3 |
p. 971-972 |
artikel |
23 |
Considerations in the Assessment of Clinical Benefit with a Focus on Pain: a Regulatory Perspective
|
St. Clair, Christopher O. |
|
|
17 |
3 |
p. 770-773 |
artikel |
24 |
Considerations in the Assessment of Clinical Benefit with a Focus on Pain: a Regulatory Perspective
|
St. Clair, Christopher O. |
|
|
17 |
3 |
p. 770-773 |
artikel |
25 |
Critical NIH Resources to Advance Therapies for Pain: Preclinical Screening Program and Phase II Human Clinical Trial Network
|
Iyengar, Smriti |
|
|
17 |
3 |
p. 932-934 |
artikel |
26 |
Critical NIH Resources to Advance Therapies for Pain: Preclinical Screening Program and Phase II Human Clinical Trial Network
|
Iyengar, Smriti |
|
|
17 |
3 |
p. 932-934 |
artikel |
27 |
Defining the Mechanism of Subarachnoid Hemorrhage–Induced Pyrexia
|
Thomas, Ajith J. |
|
|
17 |
3 |
p. 1160-1169 |
artikel |
28 |
Defining the Mechanism of Subarachnoid Hemorrhage–Induced Pyrexia
|
Thomas, Ajith J. |
|
|
17 |
3 |
p. 1160-1169 |
artikel |
29 |
Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood–Brain Barrier
|
Chiu, Po-Chuan |
|
|
17 |
3 |
p. 1184-1196 |
artikel |
30 |
Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood–Brain Barrier
|
Chiu, Po-Chuan |
|
|
17 |
3 |
p. 1184-1196 |
artikel |
31 |
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer’s Disease Pathogenesis in Cell and Animal Models
|
Wei, Hui |
|
|
17 |
3 |
p. 1087-1103 |
artikel |
32 |
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models
|
Wei, Hui |
|
|
17 |
3 |
p. 1087-1103 |
artikel |
33 |
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
|
Sharma, Puneet K. |
|
|
17 |
3 |
p. 1120-1141 |
artikel |
34 |
DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
|
Sharma, Puneet K. |
|
|
17 |
3 |
p. 1120-1141 |
artikel |
35 |
Emerging Clinical Technology: Application of Machine Learning to Chronic Pain Assessments Based on Emotional Body Maps
|
Goldstein, Pavel |
|
|
17 |
3 |
p. 774-783 |
artikel |
36 |
Emerging Clinical Technology: Application of Machine Learning to Chronic Pain Assessments Based on Emotional Body Maps
|
Goldstein, Pavel |
|
|
17 |
3 |
p. 774-783 |
artikel |
37 |
Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B
|
Kruizinga, Matthijs D. |
|
|
17 |
3 |
p. 1300-1310 |
artikel |
38 |
Finding Suitable Clinical Endpoints for a Potential Treatment of a Rare Genetic Disease: the Case of ARID1B
|
Kruizinga, Matthijs D. |
|
|
17 |
3 |
p. 1300-1310 |
artikel |
39 |
Generalization of Conditioned Contextual Anxiety and the Modulatory Effects of Anxiety Sensitivity
|
Andreatta, Marta |
|
|
17 |
3 |
p. 1239-1252 |
artikel |
40 |
Generalization of Conditioned Contextual Anxiety and the Modulatory Effects of Anxiety Sensitivity
|
Andreatta, Marta |
|
|
17 |
3 |
p. 1239-1252 |
artikel |
41 |
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
|
Kwon, Somin |
|
|
17 |
3 |
p. 935-954 |
artikel |
42 |
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
|
Kwon, Somin |
|
|
17 |
3 |
p. 935-954 |
artikel |
43 |
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
|
Prosperini, Luca |
|
|
17 |
3 |
p. 994-1004 |
artikel |
44 |
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study
|
Prosperini, Luca |
|
|
17 |
3 |
p. 994-1004 |
artikel |
45 |
Interactions Among lncRNAs/circRNAs, miRNAs, and mRNAs in Neuropathic Pain
|
Song, Ge |
|
|
17 |
3 |
p. 917-931 |
artikel |
46 |
Interactions Among lncRNAs/circRNAs, miRNAs, and mRNAs in Neuropathic Pain
|
Song, Ge |
|
|
17 |
3 |
p. 917-931 |
artikel |
47 |
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson’s Disease
|
Zou, Jing |
|
|
17 |
3 |
p. 1104-1119 |
artikel |
48 |
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease
|
Zou, Jing |
|
|
17 |
3 |
p. 1104-1119 |
artikel |
49 |
Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
|
Hegazy, Nora |
|
|
17 |
3 |
p. 1031-1047 |
artikel |
50 |
Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
|
Hegazy, Nora |
|
|
17 |
3 |
p. 1031-1047 |
artikel |
51 |
Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain
|
Tao, Xueshu |
|
|
17 |
3 |
p. 886-899 |
artikel |
52 |
Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain
|
Tao, Xueshu |
|
|
17 |
3 |
p. 886-899 |
artikel |
53 |
Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui |
|
|
17 |
3 |
p. 861-873 |
artikel |
54 |
Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui |
|
|
17 |
3 |
p. 861-874 |
artikel |
55 |
Novel Analgesics with Peripheral Targets
|
Ciotu, Cosmin I. |
|
|
17 |
3 |
p. 784-825 |
artikel |
56 |
Novel Analgesics with Peripheral Targets
|
Ciotu, Cosmin I. |
|
|
17 |
3 |
p. 784-825 |
artikel |
57 |
Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models
|
Tallon, Carolyn |
|
|
17 |
3 |
p. 973-988 |
artikel |
58 |
Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models
|
Tallon, Carolyn |
|
|
17 |
3 |
p. 973-988 |
artikel |
59 |
Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition
|
Li, Jun |
|
|
17 |
3 |
p. 1016-1030 |
artikel |
60 |
Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition
|
Li, Jun |
|
|
17 |
3 |
p. 1016-1030 |
artikel |
61 |
ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia
|
Guo, Cuiping |
|
|
17 |
3 |
p. 1271-1286 |
artikel |
62 |
ω-3PUFAs Improve Cognitive Impairments Through Ser133 Phosphorylation of CREB Upregulating BDNF/TrkB Signal in Schizophrenia
|
Guo, Cuiping |
|
|
17 |
3 |
p. 1271-1286 |
artikel |
63 |
P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain
|
Krajewski, Jeffrey L. |
|
|
17 |
3 |
p. 826-838 |
artikel |
64 |
P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain
|
Krajewski, Jeffrey L. |
|
|
17 |
3 |
p. 826-838 |
artikel |
65 |
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
|
Branger, Pierre |
|
|
17 |
3 |
p. 989-993 |
artikel |
66 |
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
|
Branger, Pierre |
|
|
17 |
3 |
p. 989-993 |
artikel |
67 |
SIRT2 Inhibition Improves Functional Motor Recovery After Peripheral Nerve Injury
|
Romeo-Guitart, David |
|
|
17 |
3 |
p. 1197-1211 |
artikel |
68 |
SIRT2 Inhibition Improves Functional Motor Recovery After Peripheral Nerve Injury
|
Romeo-Guitart, David |
|
|
17 |
3 |
p. 1197-1211 |
artikel |
69 |
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain
|
Wagner, Karen M. |
|
|
17 |
3 |
p. 900-916 |
artikel |
70 |
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain
|
Wagner, Karen M. |
|
|
17 |
3 |
p. 900-916 |
artikel |
71 |
Targeting Therapeutic Antibodies to the CNS: a Comparative Study of Intrathecal, Intravenous, and Subcutaneous Anti-Nogo A Antibody Treatment after Stroke in Rats
|
Wahl, Anna-Sophia |
|
|
17 |
3 |
p. 1153-1159 |
artikel |
72 |
Targeting Therapeutic Antibodies to the CNS: a Comparative Study of Intrathecal, Intravenous, and Subcutaneous Anti-Nogo A Antibody Treatment after Stroke in Rats
|
Wahl, Anna-Sophia |
|
|
17 |
3 |
p. 1153-1159 |
artikel |
73 |
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
|
Marschallinger, Julia |
|
|
17 |
3 |
p. 1061-1074 |
artikel |
74 |
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
|
Marschallinger, Julia |
|
|
17 |
3 |
p. 1061-1074 |
artikel |
75 |
The Nerve to Give BACE Inhibitors a Second Chance?
|
Baloh, Robert H. |
|
|
17 |
3 |
p. 966-967 |
artikel |
76 |
The Nerve to Give BACE Inhibitors a Second Chance?
|
Baloh, Robert H. |
|
|
17 |
3 |
p. 966-967 |
artikel |
77 |
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis
|
Mòdol-Caballero, Guillem |
|
|
17 |
3 |
p. 1048-1060 |
artikel |
78 |
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis
|
Mòdol-Caballero, Guillem |
|
|
17 |
3 |
p. 1048-1060 |
artikel |
79 |
The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis
|
Goldschmidt, Carolyn H. |
|
|
17 |
3 |
p. 968-970 |
artikel |
80 |
The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis
|
Goldschmidt, Carolyn H. |
|
|
17 |
3 |
p. 968-970 |
artikel |
81 |
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
|
Micheli, Laura |
|
|
17 |
3 |
p. 1005-1015 |
artikel |
82 |
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
|
Micheli, Laura |
|
|
17 |
3 |
p. 1005-1015 |
artikel |
83 |
Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration
|
Dunham, S. Richard |
|
|
17 |
3 |
p. 955-965 |
artikel |
84 |
Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration
|
Dunham, S. Richard |
|
|
17 |
3 |
p. 955-965 |
artikel |
85 |
TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis
|
Wolf, Bettina J. |
|
|
17 |
3 |
p. 1228-1238 |
artikel |
86 |
TSPO PET Identifies Different Anti-inflammatory Minocycline Treatment Response in Two Rodent Models of Epileptogenesis
|
Wolf, Bettina J. |
|
|
17 |
3 |
p. 1228-1238 |
artikel |
87 |
Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington’s Disease
|
Vas, Szilvia |
|
|
17 |
3 |
p. 1075-1086 |
artikel |
88 |
Wake-Promoting and EEG Spectral Effects of Modafinil After Acute or Chronic Administration in the R6/2 Mouse Model of Huntington's Disease
|
Vas, Szilvia |
|
|
17 |
3 |
p. 1075-1086 |
artikel |